Docoh
Loading...

SURF Surface Oncology

News

From Benzinga Pro
Surface Oncology Says Preclinical Data Supporting Therapeutic Potential Of Co's Lead Clinical Programs, SRF617 And SRF388, Presented At Society For Immunotherapy Of Cancer 2021 Annual Meeting
9 Nov 21
News, FDA, Events
Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that two scientific posters sharing
Surface Oncology Q3 EPS $(0.44) Down From $(0.39) YoY
4 Nov 21
Earnings, News
Surface Oncology (NASDAQ:SURF) reported quarterly losses of $(0.44) per share. This is a 12.82 percent decrease over losses of $(0.39) per share from the same period last year.
Surface Oncology To Present Preclinical Data For Lead Clinical Programs At Society For Immunotherapy Of Cancer 2021 Annual Meeting
2 Nov 21
News, FDA, Events
Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that scientific posters sharing
Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Oct. 22, 2021: TWTR, ROKU, BEAM, NTLA, VLD, SNAP, LPSN, SKLZ, PACB, SLGC, ARCT, VCYT, SURF
25 Oct 21
Hedge Funds, Trading Ideas, General
Twitter (TWTR) - 448,944 Roku (ROKU) - 16,743 Beam Therapeutics (BEAM) - 45,600 Intellia Therapeutics (NTLA) - 27,753 Velo3D (VLD) - 203467 Snap (SNAP)
Cathie Wood's ARK Invest Posts Fund Purchases For Thursday, Oct. 21, 2021: SKLZ, NTLA, SLGC, PACB, VCYT, ARCT, SURF
22 Oct 21
Hedge Funds, Trading Ideas, General
Skillz (SKLZ) - 2,112,856 Intellia Therapeutics (NTLA) - 28,280 Beam Therapeutics (BEAM) - 14,943 SomaLogic (SLGC) - 225,026 Pacific Biosciences of California (PACB)
Cathie Wood's ARK Invest Posts Fund Purchases For Monday, Oct. 18, 2021: NTLA, TDOC, BLDE, VLD, GENI, QSI, SURF, SLGC, VCYT
19 Oct 21
Hedge Funds, Trading Ideas, General
Intellia Therapeutics (NTLA) - 26,537 Teladoc Health (TDOC) - 100 Blade Air Mobility (BLDE) - 156,754 Velo3D (VLD) - 1,200 Genius Sports (GENI) - 42,223 Quantum-Si (QSI)
Cathie Wood's ARK Invest Posts Fund Purchases For Thursday, Oct. 7, 2021: BEAM, SGFY, TWOU, SSYS, ACHR, BLDE, VLD, MKFG, NIU, TDOC, CND, GENI, SLGC, SURF, DYNS, QSI, PRNT
8 Oct 21
Hedge Funds, Trading Ideas, General
Beam Therapeutics (BEAM) - 85,469 Shares
Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Oct. 6, 2021: DNA, PATH, SGFY, PACB, BEAM, SSYS, TWOU, BLDE, VLD, NIU, MKFG,, ACHR, TDOC, SQ, VUZI, ADPT, SLGC, SURF, QSI, DYNS, PRNT
7 Oct 21
Hedge Funds, Trading Ideas, General
Ginkgo Bioworks (DNA) - 8,264,233 Shares UiPath (PATH) - 580,632 SIgnify Health (SGFY) - 325,861 Pacific Biosciences Of California (PACB) - 57,511 Beam Therapeutics (BEAM) - 93,625 Stratasys (SSYS) - 77,800 2U
Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Oct. 5, 2021: TDOC, PACB, BEAM, SGFY, TWOU, DNA, SSYS, MKFG, ACHR, BLDE, VLD, NIU, SQ, VUZI, ADPT, SURF, QSI, SLGC, MASS, DYNS, PATH, HOOD, TOST, PRNT
6 Oct 21
Hedge Funds, Trading Ideas, General
Teladoc Health (TDOC) - 154,175 Shares Pacific Biosciences Of California (PACB) - 783,580 Beam Therapeutics (BEAM) - 104,491 Signify Health (SGFY) - 749,117 2U (TWOU) - 166,427 Gingko Bioworks (DNA) -
Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Oct. 1, 2021: PACB, BEAM, DNA, AVAV, ACHR, TWOU, VCYT, CRSP, SURF, PSNL, QSI
4 Oct 21
Hedge Funds, Trading Ideas, General
Pacific Biosciences of California (PACB) - 371,100 Beam Therapeutics (BEAM) - 134,265 Ginkgo Bioworks Holdings (DNA) - 1,994,672 Aerovironment (AVAV) - 25,300 Archer Aviation (ACHR)
Cathie Wood's ARK Invest Posts Fund Purchases For Thursday, Sept. 30, 2021: BEAM, DNA, AVAV, ACHR, PD, TWOU, VCYT, QSI, SURF, MASS, PACB, DYNS, BLDE
1 Oct 21
Hedge Funds, Trading Ideas, General
Beam Therapeutics (BEAM) - 130,645 Shares Gingko Bioworks (DNA) - 173,518 AeroVironment (AVAV) - 16,200 Archer Aviation (ACHR) - 95,564 PagerDuty (PD) 2U (TWOU) - 12,749 Veracyte (VCYT) - 6,478 Quantum-Si (QSI)
35 Stocks Moving In Monday's Mid-Day Session
20 Sep 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) jumped 145% to $6.86 after declining around 17% on Friday.
48 Biggest Movers From Friday
20 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.
25 Stocks Moving In Friday's Mid-Day Session
17 Sep 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 92.7% to $17.35 after the company announced its media unit has entered into an agreement with FOX Networks to broadcast the Italian Serie B championship across the USA and the Caribbean.
12 Health Care Stocks Moving In Friday's Pre-Market Session
17 Sep 21
Pre-Market Outlook, Markets, Movers
15 Stocks Moving in Friday's Pre-Market Session
17 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) rose 42% to $3.21 in pre-market trading.
How Bad Are Surface Oncology's Earnings? | Return On Capital Employed
8 Sep 21
Earnings
Surface Oncology (NASDAQ:SURF) brought in sales totaling $515.00 thousand during Q2 according to data provided by Benzinga Pro.However, earnings decreased 27.67%, resulting in a loss of $18.59 million.

Press releases

From Benzinga Pro
Preclinical Data Supporting Therapeutic Potential of Surface Oncology's Lead Clinical Programs, SRF617 and SRF388, Presented at the Society for Immunotherapy of Cancer 2021 Annual Meeting
9 Nov 21
Health Care, Press Releases, General
CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2021
4 Nov 21
Earnings, Press Releases
CAMBRIDGE, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today
Surface Oncology to Present Preclinical Data for Lead Clinical Programs at the Society for Immunotherapy of Cancer 2021 Annual Meeting
2 Nov 21
News, Press Releases
CAMBRIDGE, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today
Global Radiotherapy Market Expected To Reach $7.3 Billion with a CAGR Of 4.2% By 2026
20 Sep 21
Small Cap, Opinion, Press Releases
PALM BEACH, Fla., Sept. 20, 2021 /PRNewswire/ -- Over the last decade, the radiotherapy devices market has seen significant technological advancements. These advancements have helped in the development of more